Pharmaceutical and healthcare brands spent an estimated $3.34 billion on linear TV alone in 2025 so far\u2013that\u2019s nearly 14% of all U.S. TV ad spend. With stakes this high, it\u2019s never been more important for these brands to not only reach and measure their desired audience, but to leverage advanced technology to help drive optimization.\u00a0<\/p>\n\n\n\n
That is why iSpot and Swoop, a leading provider of AI-driven healthcare solutions, are teaming up to bring clarity to healthcare marketing at a time when pharma advertisers are facing mounting pressure to prove the value of their ads. <\/p>\n\n\n\n
By integrating iSpot\u2019s trusted cross-platform TV ad measurement with Swoop\u2019s privacy-compliant, AI-driven audience solutions, advertisers can now better understand who their targets are, what media they engage with and how best to reach them through advertising\u2014all in a privacy-compliant manner.<\/p>\n\n\n\n
Now, advertisers can leverage iSpot\u2019s Unified Measurement<\/a> and outcomes solutions<\/a> against Swoop\u2019s highly specific, cross-platform audiences, delivering clearer insights that pharmaceutical and healthcare brands can use to drive more efficient and effective media investments. This consumer-first approach ultimately improves outcomes through smarter, more meaningful engagement.<\/p>\n\n\n\n Read the full news below.<\/p>\n\n\n\n iSpot and Swoop Partner to Bring Independent Measurement and Transparency to Healthcare Marketing<\/strong><\/p>\n\n\n\n Privacy-complaint targeting and measurement will help pharma brands optimize reach and frequency across TV platforms<\/em><\/p>\n\n\n\n BELLEVUE, WA, August 21, 2025 \u2013 <\/strong>iSpot<\/a>, the cross-platform TV ad measurement company and Swoop<\/a>, a leader in AI-driven, data-powered, and omnichannel healthcare marketing, today announced an industry integration that gives advertisers an effective way to measure, understand and optimize on Swoop\u2019s privacy-compliant DTC and HCP audiences.<\/p>\n\n\n\n This partnership allows advertisers to leverage iSpot\u2019s Unified Measurement and Outcomes solutions on Swoop\u2019s data-driven audience segments to gain insights into cross-platform viewership and exposure.<\/p>\n\n\n\n Understanding how and where Swoop\u2019s audiences engage with media helps advertisers identify and implement efficient, scalable ways to engage their ideal consumers and understand the optimal reach and frequency of their online omnichannel campaigns. This enables healthcare advertisers to further drive down-funnel business outcomes and improve patient outcomes. <\/p>\n\n\n\n \u201cPharmaceutical and healthcare advertising on linear TV alone accounted for nearly 14%, some $3.34 billion, of all <\/em>linear U.S TV ad spend in 2025, according to a recent iSpot report<\/a>,\u201d said Tom Keaveny, EVP Business Development, iSpot. \u201cWe\u2019re excited about our partnership with Swoop \u2013 it gives healthcare marketers operating in today\u2019s dynamic media marketplace an opportunity to leverage iSpot\u2019s trusted, cross-channel media measurement in order to win.\u201d<\/p>\n\n\n\n \u201cHealth-related marketers need to understand and reach the right consumers and healthcare providers across the multitude of online platforms available with efficiency and scale,\u201d said Kurt Robinson, EVP, Business Development, Swoop. \u201cWe\u2019re excited to work alongside iSpot and give the industry a way to measure this efficacy on cross-platform viewing behavior.\u201d<\/p>\n\n\n\n This collaboration is available across the entire U.S. healthcare advertising market, which was approximately $23.8 billion in 2024 and projected to balloon to an estimated $35.2 billion by 2034, according to Claight Corporation. <\/p>\n\n\n\n
\n\n\n\n